1. Home
  2. KRNT vs GOSS Comparison

KRNT vs GOSS Comparison

Compare KRNT & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kornit Digital Ltd.

KRNT

Kornit Digital Ltd.

HOLD

Current Price

$13.86

Market Cap

695.1M

Sector

Industrials

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.78

Market Cap

796.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNT
GOSS
Founded
2002
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
695.1M
796.2M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
KRNT
GOSS
Price
$13.86
$2.78
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$19.75
$8.83
AVG Volume (30 Days)
290.8K
4.7M
Earning Date
02-11-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$210,041,000.00
$44,051,000.00
Revenue This Year
$3.86
N/A
Revenue Next Year
$2.57
$6.41
P/E Ratio
N/A
N/A
Revenue Growth
5.17
N/A
52 Week Low
$11.93
$0.76
52 Week High
$31.24
$3.87

Technical Indicators

Market Signals
Indicator
KRNT
GOSS
Relative Strength Index (RSI) 41.92 47.95
Support Level $13.64 $2.38
Resistance Level $14.65 $3.00
Average True Range (ATR) 0.51 0.22
MACD -0.12 0.03
Stochastic Oscillator 9.73 66.26

Price Performance

Historical Comparison
KRNT
GOSS

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: